Discontinuing caffeine in preterm infants at 33-35 weeks corrected gestational age: Failure rate and predictive factors

Journal of Neonatal-perinatal Medicine
W HaddadRong Guo

Abstract

To examine the success rate of our current practice of discontinuing caffeine at 33 0/7-35 6/7 weeks post menstrual age (PMA), as well as factors that predict the success or failure of discontinuation. A retrospective chart review of infants born before 34 weeks gestational age between 2006-2012. Data collected included demographics, and other comorbidities mainly complications of prematurity. 647 treated infants had caffeine discontinued at 33-35 PMA before discharge or transfer. 64 (10%) infants failed discontinuation and had caffeine restarted. Most (77%) of those who failed started having monitor alarms within 7 days of discontinuation. BPD and Hispanic ethnicity were predictive of weaning failure (p < 0.05). Caffeine can be discontinued at 33-35 weeks PMA with a failure rate of 10%. BPD and Hispanic ethnicity are predictive of failure. It is generally safe to discharge infants seven days after the caffeine was discontinued if no significant monitor events occur during that time.

References

Nov 14, 1997·Pediatrics·R A DarnallM Robinson
Nov 21, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J M HascoetM J Boutroy
May 19, 2006·The New England Journal of Medicine·Barbara SchmidtUNKNOWN Caffeine for Apnea of Prematurity Trial Group
Nov 9, 2007·The New England Journal of Medicine·Barbara SchmidtUNKNOWN Caffeine for Apnea of Prematurity Trial Group
Mar 10, 2009·European Journal of Pediatrics·Zainab KassimGerrard F Rafferty
May 1, 2009·Pediatrics·Susan Bakewell-SachsScott A Lorch
Feb 9, 2011·European Journal of Pediatrics·Jing ZhaoDezhi Mu
Oct 4, 2012·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·S PiconeP Paolillo
Jan 22, 2014·JAMA Pediatrics·Lawrence M RheinUNKNOWN Caffeine Pilot Study Group

❮ Previous
Next ❯

Citations

Nov 13, 2015·Journal of Perinatology : Official Journal of the California Perinatal Association·J DoyleJ DeCristofaro
Nov 24, 2019·Journal of Perinatology : Official Journal of the California Perinatal Association·Dabin JiRachel G Greenberg
Dec 12, 2021·BMJ Open Respiratory Research·Tricia AdjeiCaroline Hartley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Minerva pediatrica
S FanaroV Vigi
Archives of Disease in Childhood. Fetal and Neonatal Edition
M ThomasS Calvert
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
S DucrocqF Gold
Acta pediátrica española
A ARBELO
© 2022 Meta ULC. All rights reserved